Skip to main content
. Author manuscript; available in PMC: 2020 Jan 15.
Published in final edited form as: Bioorg Med Chem. 2018 Nov 14;27(2):255–264. doi: 10.1016/j.bmc.2018.11.022

Fig. 1.

Fig. 1.

Chemical structures of [177Lu]PSMA-617, compounds 1-3, and ZJ-43. (a) [177Lu]PSMA-617 contains a component acting as a urea-based GCPII inhibitor that binds to the active site. (b) Compounds 1-3 possess either a urea or carbamate moiety. (c) Chemical structure of ZJ-43.